Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma.
about
Comparison of commercial real-time PCR assays for quantification of Epstein-Barr virus DNA.Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers.Genomic targets in saliva.A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer.Can Epstein-Barr virus DNA load in nasopharyngeal brushings or whole blood predict recurrent nasopharyngeal carcinoma in a non-endemic region? A prospective nationwide study of the Dutch Head and Neck Oncology Cooperative Group.Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma.Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.The clinical utility of plasma Epstein-Barr virus DNA assays in nasopharyngeal carcinoma: the dawn of a new era?: a systematic review and meta-analysis of 7836 casesTransrenal DNA testing: progress and perspectives.Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinomaThe clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.Centrifugation: an important pre-analytic procedure that influences plasma microRNA quantification during blood processing.Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches.Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications.Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma.Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma.Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma.The role of plasma Epstein-Barr virus DNA in the management of recurrent nasopharyngeal carcinoma.Plasma Epstein-Barr virus immunoglobulin A and DNA for nasopharyngeal carcinoma screening in the United States.Correlation of Epstein-Barr virus DNA in cell-free plasma, functional imaging and clinical course in locally advanced nasopharyngeal cancer: a pilot study.
P2860
Q33859109-078685AC-119E-4B84-94CA-642BF4E9FE4BQ33947851-7BF823C5-08E4-40F0-985C-7587CDBEEA8FQ34023027-13D4D7C0-DCA7-4F94-BB5D-4CC1760C1E65Q35121627-0ED6B46C-BA72-4843-9189-7D7EFA91CFEEQ35619542-308F0F9E-412D-42EA-8AA8-011166006D0AQ35789774-883BF67E-4559-49F1-A087-DB457EC8CF20Q36092875-381F3EF2-6B60-4B7A-939E-7FCD5D8418AFQ36152889-EFE71A9E-828B-4868-8AAE-1F3133E1A418Q36411665-36AE707E-3587-4B62-B558-8932558238A1Q36782643-499BE868-C3E9-4899-A59D-478BC60B4DEEQ37225239-00194292-9595-4B3A-BDB1-3CC9CCB8724FQ37409781-BDE4877C-129D-4F6E-8897-80EE2E169842Q37950284-25C49894-93FC-4811-83BA-374EA61B633FQ38087239-D85556D5-9298-4C94-991E-AD54E3051D32Q38270678-773B04CF-28A9-433A-A974-D7E35E64471FQ40333888-2F787ED9-BB9A-4ECD-A576-5E484B35BD31Q42145376-BFC2B3FD-83E4-41B4-B02D-A0FC2D4C7C52Q45351163-834BF38B-5E6E-485A-9A9F-3A702676298AQ45403303-C91CA9B4-1A86-4D8C-A577-2EA6F1C1E1DCQ45593276-841C3238-DBD4-4879-A6F9-55D37EADE540
P2860
Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma.
@ast
Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma.
@en
type
label
Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma.
@ast
Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma.
@en
prefLabel
Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma.
@ast
Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma.
@en
P1476
Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma.
@en
P2093
K C Allen Chan
Y M Dennis Lo
P304
P356
10.1016/S1044579X02000913
P577
2002-12-01T00:00:00Z